NASDAQ:KRYS

Krystal Biotech Stock Predictions

etoro logo Buy KRYS
*Your capital is at risk
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KRYS Prediction Chart

KRYS Predictions History

Latest community submissions for KRYS.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 12, 2026 $257.91 -1.34% $272.13 X 94.78% 0
Jan 12, 2026 $259.22 -0.84% $272.13 X 95.26% 0
Jan 12, 2026 $290.36 +11.07% $272.13 V 93.30% 1
Oct 29, 2025 $187.12 -1.34% $185.05 V 98.88% 2
Oct 29, 2025 $191.23 +0.84% $185.05 X 96.66% 0
Oct 29, 2025 Bullish $185.05 X 0
Aug 5, 2025 $137.53 +1.92% $137.35 V 99.87% 6
Aug 5, 2025 $136.56 +1.20% $137.35 V 99.42% 4
Aug 5, 2025 Bullish $137.35 X 1
JS JS Pro
May 7, 2024 $155.45 -0.95% $161.76 X 96.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KRYS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KRYSTAL BIOTECH INC
Krystal Biotech
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE